To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma
Clinical trial NCT01568762 · COMPLETED
Trial details
- NCT number
- NCT01568762
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-07-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.